Literature DB >> 8250838

In vitro translation of androgen receptor cRNA results in an activated androgen receptor protein.

G G Kuiper1, P E de Ruiter, J Trapman, G Jenster, A O Brinkmann.   

Abstract

Translation of androgen receptor (AR) cRNA in a reticulocyte lysate and subsequent analysis of the translation products by SDS/PAGE showed a protein with an apparent molecular mass of 108 kDa. Scatchard-plot analysis revealed a single binding component with high affinity for R1881 (Kd = 0.3 nM). All AR molecules synthesized specifically bound steroid. No evidence for AR phosphorylation during in vitro synthesis was found. When AR was labelled with [3H]R1881 and analysed on sucrose-density gradients, a complex of approx. 6 S was observed. The complex was shifted to a higher sedimentation coefficient after incubation with a monoclonal AR antibody directed against an epitope in the DNA-binding domain. In the presence as well as the absence of hormone, AR molecules were able to bind to DNA-cellulose without an activation step. Gel retardation assays revealed that the AR forms complexes with a DNA element containing glucocorticoid-responsive element/androgen-responsive element sequences. Receptor-DNA interactions were stabilized by different polyclonal antibodies directed against either the N- or C-terminal part of the AR and were abolished by an antibody directed against the DNA-binding domain of the receptor. In conclusion, translation of AR cRNA in vitro yields an activated AR protein which binds steroid with high affinity. It is proposed that AR antibodies enhance AR-DNA binding by stabilizing AR dimers when bound to DNA.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250838      PMCID: PMC1137669          DOI: 10.1042/bj2960161

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

Review 1.  Gene regulation by steroid hormones.

Authors:  M Beato
Journal:  Cell       Date:  1989-02-10       Impact factor: 41.582

2.  In vitro transcription enhancement by purified derivatives of the glucocorticoid receptor.

Authors:  L P Freedman; S K Yoshinaga; J N Vanderbilt; K R Yamamoto
Journal:  Science       Date:  1989-07-21       Impact factor: 47.728

3.  Translation of glucocorticoid receptor mRNA in vitro yields a nonactivated protein.

Authors:  M Denis; J A Gustafsson
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

4.  Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation.

Authors:  S Y Tsai; J Carlstedt-Duke; N L Weigel; K Dahlman; J A Gustafsson; M J Tsai; B W O'Malley
Journal:  Cell       Date:  1988-10-21       Impact factor: 41.582

Review 5.  Nuclear extracts enhance gel retardation with androgen and glucocorticoid receptor DNA-binding domains.

Authors:  P De Vos; F Claessens; L Celis; W Heyns; W Rombauts; G Verhoeven
Journal:  Ann N Y Acad Sci       Date:  1993-06-11       Impact factor: 5.691

6.  Mammalian glucocorticoid receptor derivatives enhance transcription in yeast.

Authors:  M Schena; K R Yamamoto
Journal:  Science       Date:  1988-08-19       Impact factor: 47.728

7.  Partial purification and characterisation of the human skin fibroblast androgen receptor: detection of abnormal receptor complexes in cells from patients with androgen insensitivity syndromes.

Authors:  I J McEwan; D A Rowney; M B Hodgins
Journal:  J Steroid Biochem       Date:  1989-06       Impact factor: 4.292

8.  Differential effects of molybdate on the hydrodynamic and DNA-binding properties of the non-activated and activated forms of the androgen receptor in calf uterus.

Authors:  W de Boer; J Bolt; A O Brinkmann; E Mulder
Journal:  Biochim Biophys Acta       Date:  1986-11-28

9.  Functional dissection of the hormone and DNA binding activities of the glucocorticoid receptor.

Authors:  S Rusconi; K R Yamamoto
Journal:  EMBO J       Date:  1987-05       Impact factor: 11.598

10.  Tissue-specific and steroid-dependent interaction of transcription factors with the oestrogen-inducible apoVLDL II promoter in vivo.

Authors:  J Wijnholds; J N Philipsen; G Ab
Journal:  EMBO J       Date:  1988-09       Impact factor: 11.598

View more
  3 in total

1.  Molecular analysis of the androgen-receptor gene in a family with receptor-positive partial androgen insensitivity: an unusual type of intronic mutation.

Authors:  H T Brüggenwirth; A L Boehmer; S Ramnarain; M C Verleun-Mooijman; D P Satijn; J Trapman; J A Grootegoed; A O Brinkmann
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

2.  Clinical characteristics, AR gene variants, and functional domains in 64 patients with androgen insensitivity syndrome.

Authors:  Q Liu; X Yin; P Li
Journal:  J Endocrinol Invest       Date:  2022-08-16       Impact factor: 5.467

3.  Human androgen receptor expressed in HeLa cells activates transcription in vitro.

Authors:  P De Vos; J Schmitt; G Verhoeven; H G Stunnenberg
Journal:  Nucleic Acids Res       Date:  1994-04-11       Impact factor: 16.971

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.